Summary
Donald Trump announced plans to impose 100% tariffs on imported generic drugs starting in 2028, escalating to 200% after a year, to encourage reshoring of pharmaceutical production. Experts warn this policy could significantly impact drug prices and availability for Americans, as generic drugs constitute over 90% of U.S. prescriptions, with India and China being major suppliers.